Rani Therapeutics Holdings IncNASDAQ:RANI
- LAST PRICE5.5000
- TODAY'S CHANGE (%)0.3800 (7.4219%)
- Bid / Lots5.3000/ 1
- Ask / Lots6.0000/ 20
- Open / Previous Close5.2700 / 5.1200
- Day Range
- 52 Week Range
- Volume136,087
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | RANI |
|---|---|---|
| 09:32 ET | 5287 | 5.27 |
| 09:36 ET | 2100 | 5.28 |
| 09:48 ET | 191 | 5.17 |
| 09:54 ET | 13662 | 5.2532 |
| 09:56 ET | 738 | 5.4 |
| 09:57 ET | 678 | 5.4072 |
| 09:59 ET | 1000 | 5.4003 |
| 10:01 ET | 400 | 5.4019 |
| 10:03 ET | 200 | 5.4486 |
| 10:06 ET | 1732 | 5.545 |
| 10:08 ET | 1190 | 5.5297 |
| 10:10 ET | 5239 | 5.7399 |
| 10:12 ET | 408 | 5.7399 |
| 10:14 ET | 1174 | 5.5717 |
| 10:17 ET | 425 | 5.65 |
| 10:30 ET | 1000 | 5.61 |
| 10:33 ET | 5828 | 5.55 |
| 10:39 ET | 1000 | 5.495 |
| 10:42 ET | 213 | 5.4201 |
| 11:24 ET | 500 | 5.34 |
| 11:26 ET | 100 | 5.4799 |
| 11:40 ET | 100 | 5.32 |
| 11:54 ET | 100 | 5.4 |
| 11:56 ET | 2600 | 5.36 |
| 11:58 ET | 400 | 5.4 |
| 12:00 ET | 1209 | 5.33 |
| 12:03 ET | 100 | 5.33 |
| 12:16 ET | 500 | 5.3293 |
| 12:23 ET | 298 | 5.3 |
| 12:25 ET | 100 | 5.28 |
| 12:30 ET | 365 | 5.3 |
| 12:39 ET | 2000 | 5.27 |
| 12:41 ET | 830 | 5.25 |
| 12:43 ET | 2290 | 5.31 |
| 12:45 ET | 400 | 5.31 |
| 12:50 ET | 300 | 5.28 |
| 12:52 ET | 4500 | 5.33 |
| 12:56 ET | 1100 | 5.35 |
| 12:59 ET | 695 | 5.4 |
| 01:01 ET | 1635 | 5.41 |
| 01:12 ET | 400 | 5.42 |
| 01:14 ET | 3416 | 5.435 |
| 01:15 ET | 1500 | 5.435 |
| 01:24 ET | 3900 | 5.36 |
| 01:26 ET | 4511 | 5.4 |
| 01:28 ET | 100 | 5.4 |
| 01:46 ET | 260 | 5.41 |
| 01:48 ET | 100 | 5.42 |
| 01:50 ET | 215 | 5.41 |
| 01:57 ET | 100 | 5.41 |
| 02:00 ET | 1300 | 5.48 |
| 02:02 ET | 4985 | 5.45 |
| 02:04 ET | 200 | 5.46 |
| 02:06 ET | 200 | 5.46 |
| 02:09 ET | 3114 | 5.4501 |
| 02:11 ET | 500 | 5.45 |
| 02:13 ET | 217 | 5.45 |
| 02:38 ET | 200 | 5.44 |
| 02:40 ET | 673 | 5.45 |
| 02:44 ET | 100 | 5.45 |
| 02:45 ET | 556 | 5.44 |
| 02:47 ET | 456 | 5.44 |
| 03:03 ET | 200 | 5.41 |
| 03:09 ET | 125 | 5.41 |
| 03:12 ET | 486 | 5.41 |
| 03:20 ET | 100 | 5.4 |
| 03:30 ET | 500 | 5.41 |
| 03:32 ET | 200 | 5.41 |
| 03:36 ET | 100 | 5.41 |
| 03:38 ET | 161 | 5.41 |
| 03:39 ET | 200 | 5.47 |
| 03:45 ET | 100 | 5.45 |
| 03:48 ET | 400 | 5.3 |
| 03:50 ET | 1300 | 5.38 |
| 03:52 ET | 4170 | 5.48 |
| 03:54 ET | 4100 | 5.47 |
| 03:56 ET | 400 | 5.45 |
| 03:57 ET | 488 | 5.45 |
| 03:59 ET | 4290 | 5.5 |
May 14, 2024
Rani Therapeutics to Participate in May Investor Conferences, from 8:00AM ET on Tuesday May 14, 2024 by Dow Jones
8:00AM ET on Tuesday May 14, 2024 by Dow Jones
May 9, 2024
DJ Rani Therapeutics Is Maintained at Buy by BTIG, from 3:20PM ET on Thursday May 09, 2024 by Dow Jones
3:20PM ET on Thursday May 09, 2024 by Dow JonesRani Therapeutics to Present Clinical and Preclinical Data on Oral Delivery of an Ustekinumab Biosimilar via the RaniPill(R) Capsule at Digestive Disease Week 2024, from 8:00AM ET on Thursday May 09, 2024 by Dow Jones
8:00AM ET on Thursday May 09, 2024 by Dow Jones
May 7, 2024
DJ Rani Therapeutics Is Maintained at Buy by HC Wainwright & Co., from 6:48AM ET on Tuesday May 07, 2024 by Dow Jones
6:48AM ET on Tuesday May 07, 2024 by Dow Jones
May 6, 2024
Rani Therapeutics Reports First Quarter 2024 Financial Results; Provides Corporate Update, from 4:05PM ET on Monday May 06, 2024 by Dow Jones
4:05PM ET on Monday May 06, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Rani Therapeutics Holdings Inc | 277.3M | -4.3x | --- |
Black Diamond Therapeutics Inc | 268.9M | -2.8x | --- |
Candel Therapeutics Inc | 264.7M | -6.9x | --- |
ATAI Life Sciences NV | 262.8M | -6.5x | --- |
Inovio Pharmaceuticals Inc | 262.5M | -1.8x | --- |
Inozyme Pharma Inc | 298.1M | -3.5x | --- |
Company Information
Rani Therapeutics Holdings, Inc. is a clinical-stage biotherapeutics company. The Company is focused on advancing technologies to enable the administration of biologics and drugs orally, to provide patients, physicians, and healthcare systems with a convenient alternative to painful injections. It has developed a drug-agnostic oral delivery platform, the RaniPill capsule, which is designed to deliver a variety of drug substances, including antibodies, proteins, peptides, and oligonucleotides. The RaniPill GO, is designed to deliver up to a three micrograms (mg) dose of drug with high bioavailability. The capsule includes a coating designed to withstand stomach acid but dissolve in the jejunum portion of the small intestine. Its pipeline includes RT-102, RT-105, RT-111 and RT-110. It is also developing a high-capacity version of the RaniPill capsule known as the RaniPill HC, which is intended to enable delivery of drug payloads up to 200uL in liquid form with high bioavailability.
Contact Information
- Headquarters
- 2051 Ringwood AvenueSAN JOSE, CA, United States 95131
- Phone
- 408-457-3700
- Fax
- 302-655-5049
Executives
- Executive Chairman of the Board
- Mir Imran
- Chief Executive Officer, Director
- Talat Imran
- Chief Financial Officer
- Svai Sanford
- Chief Scientific Officer
- Mir Hashim
- General Counsel
- Eric Groen
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $277.3M |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 50.4M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $-1.29 |
Book Value | $0.27 |
P/E Ratio | -4.3x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
